Mcsnacks H Tupack
:
Outlook is not good. They are loaded down with too many shares when the market is struggling for volume. They will reverse split soon to stay listed.
Mcsnacks H Tupack
:
I would sell them and buy into $Evofem Biosciences (EVFM.US)$. They have an announce coming on phase 3 results that will put them into an FDA decision later. And they have a low amount of shares with a institutional investor buying in.
maddhatter
:
EVFM is old news. Sad, but that’s how the market works. Women’s rights are not a hot topic anymore. SCOTUS pissed me off and made a good gain on this stock but bailed when it was apparently time.
Mcsnacks H Tupack : Outlook is not good. They are loaded down with too many shares when the market is struggling for volume. They will reverse split soon to stay listed.
Mcsnacks H Tupack : I would sell them and buy into $Evofem Biosciences (EVFM.US)$. They have an announce coming on phase 3 results that will put them into an FDA decision later. And they have a low amount of shares with a institutional investor buying in.
venda akka OP : Thanks a lot MASTER
maddhatter : EVFM is old news. Sad, but that’s how the market works. Women’s rights are not a hot topic anymore. SCOTUS pissed me off and made a good gain on this stock but bailed when it was apparently time.